ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 127 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $837,000 | -2.0% | 11,904 | -1.1% | 0.01% | 0.0% |
| Q3 2016 | $854,000 | +6.2% | 12,039 | -26.8% | 0.01% | 0.0% |
| Q2 2016 | $804,000 | +1.9% | 16,453 | +32.0% | 0.01% | 0.0% |
| Q1 2016 | $789,000 | -53.3% | 12,464 | -17.2% | 0.01% | -50.0% |
| Q4 2015 | $1,690,000 | +16.1% | 15,059 | -0.4% | 0.01% | +20.0% |
| Q3 2015 | $1,456,000 | -38.8% | 15,120 | -34.9% | 0.01% | -33.3% |
| Q2 2015 | $2,379,000 | +22.1% | 23,234 | -26.0% | 0.02% | +66.7% |
| Q1 2015 | $1,949,000 | +17.9% | 31,386 | -16.7% | 0.01% | +28.6% |
| Q4 2014 | $1,653,000 | -38.7% | 37,673 | -21.0% | 0.01% | -36.4% |
| Q3 2014 | $2,698,000 | +15.8% | 47,682 | -8.1% | 0.01% | +10.0% |
| Q2 2014 | $2,330,000 | +97.0% | 51,907 | +114.6% | 0.01% | +100.0% |
| Q1 2014 | $1,183,000 | – | 24,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |